Blue Bell Private Wealth Management LLC Boosts Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Blue Bell Private Wealth Management LLC lifted its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 391.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,657 shares of the company’s stock after purchasing an additional 57,865 shares during the period. Blue Bell Private Wealth Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $1,064,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Stratos Wealth Advisors LLC purchased a new stake in BlackRock Health Sciences Term Trust during the 4th quarter worth $170,000. Kingswood Wealth Advisors LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth about $295,000. B. Riley Wealth Advisors Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust by 4.8% in the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after acquiring an additional 796 shares in the last quarter. Walleye Capital LLC boosted its holdings in BlackRock Health Sciences Term Trust by 45.5% in the third quarter. Walleye Capital LLC now owns 27,907 shares of the company’s stock valued at $402,000 after purchasing an additional 8,732 shares during the last quarter. Finally, Almitas Capital LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter valued at approximately $1,501,000.

BlackRock Health Sciences Term Trust Price Performance

BMEZ stock traded up 0.03 during midday trading on Friday, hitting 15.83. 148,800 shares of the company’s stock were exchanged, compared to its average volume of 353,262. The firm has a 50 day moving average price of 16.08 and a 200-day moving average price of 14.87. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.95.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Monday, April 15th will be issued a dividend of $0.09 per share. This represents a $1.08 annualized dividend and a yield of 6.82%. The ex-dividend date of this dividend is Friday, April 12th.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. purchased 46,421 shares of BlackRock Health Sciences Term Trust stock in a transaction dated Monday, April 1st. The shares were acquired at an average price of 16.33 per share, with a total value of 758,054.93. Following the completion of the transaction, the insider now owns 20,538,431 shares of the company’s stock, valued at approximately 335,392,578.23. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. In the last 90 days, insiders purchased 2,243,363 shares of company stock valued at $35,173,309.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.